| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50005 |
J-111 |
human |
blood |
HeLa markers* |
|
| 2 | general cells |
IFO50013 |
RPMI 8226 |
human |
peripheral blood |
Ig lambda light chain-secreting. |
|
| 3 | general cells |
IFO50040 |
Namalwa |
human |
lymphoblastoid |
This cell line produce interferon. |
|
| 4 | general cells |
IFO50112 |
TaD-1 |
rat |
thymus |
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat) |
|
| 5 | general cells |
IFO50221 |
N18-RE-105 |
mouse x rat |
|
Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina. |
|
| 6 | general cells |
IFO50269 |
GH1 |
rat |
pituitary gland |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
| 7 | general cells |
IFO50294 |
MEG-01SSF |
human |
bone marrow |
leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium |
|
| 8 | general cells |
IFO50303 |
T98G |
human |
brain |
glioblastoma, multiforme |
|
| 9 | general cells |
IFO50362 |
MOLT-4 |
human |
peripheral blood |
leukemia, acute T lymphoblastic |
|
| 10 | general cells |
IFO50411 |
A-431 |
human |
epidermoid |
epidermoid carcinoma, high expression of EGF receptor |
|
| 11 | general cells |
IFO50432 |
KP-N-RT-BM-1 |
human |
neuroblastoma |
neuroblastoma, from bone marrow, neuronal and Schwannian differentiation |
|
| 12 | general cells |
IFO50467 |
NMC-G1 |
human |
brain |
glioma, FGF-9-producing |
|
| 13 | general cells |
IFO50475 |
NOMO-1s |
human |
peripheral blood |
This cell line is useful for studying the differentiation and maturation of monocytes. |
|
| 14 | general cells |
IFO50488 |
OUMS-27 |
human |
bone, left proimal humerus |
chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing |
|
| 15 | general cells |
IFO50490 |
MDM2-RNB |
rat |
brain |
human MDM2 protein-expressing astrocyte cell line, (Wistar rat) |
|
| 16 | general cells |
JCRB0006 |
HL60RG |
human |
peripheral blood |
Subline of the HL60 having faster growth rate but the capabilities of the differentiation by TPA or etc were declined. |
|
| 17 | general cells |
JCRB0019 |
K562 |
human |
pleural effusion |
Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis. |
|
| 18 | general cells |
JCRB0025 |
BRL-3A |
rat |
liver |
MSA (somatomedin-like) protein producing, (Buffalo rat) |
|
| 19 | general cells |
JCRB0055 |
LU65B |
human |
lung |
giant cell carcinoma |
|
| 20 | general cells |
JCRB0126.1 |
KOSC-2 cl3-43 |
human |
oral floor |
Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name. |
|
| 21 | general cells |
JCRB0130.1 |
PC12.P3 |
rat |
|
PC-12 derivative adapted to serum-free culture, direct deposition by original developer. |
|
| 22 | general cells |
JCRB0134 |
MCF-7 |
human |
pleural effusion |
Human metastatic mammary carcinoma cell line. |
|
| 23 | general cells |
JCRB0143.0 |
F2408 pZipNeo |
rat |
whole body of embryo |
F2408 cell line transfected with pZipNeo plasmid alone as a control against pZE2 transfected F2408 cell line series. |
|
| 24 | general cells |
JCRB0144.1B |
LYM-1.P3B |
rat |
|
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
| 25 | general cells |
JCRB0160 |
LI90 |
human |
liver |
Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm. |
|
| 26 | general cells |
JCRB0163 |
HL60(S) |
human |
peripheral blood |
Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. |
|
| 27 | general cells |
JCRB0199 |
huH-1 |
human |
liver |
Human hepatoma cell line. |
|
| 28 | general cells |
JCRB0232 |
SKG-IIIa |
human |
cervix |
cervical epidermoid carcinoma, clear cell type |
|
| 29 | general cells |
JCRB0236 |
KG-1-C |
human |
brain |
mixed glioma, GFAP-negative, S-100-positive (growth is very slow). |
|
| 30 | general cells |
JCRB0405 |
HLF |
human |
liver |
hepatoma, non-differentiated |
|
| 31 | general cells |
JCRB0501 |
TIG-1-20 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20 |
|
| 32 | general cells |
JCRB0608 |
JTC19 |
rat |
lung |
lung, (JAR-1 rat) |
|
| 33 | general cells |
JCRB0612 |
GOTO |
human |
adrenal gland |
neuroblastoma, adrenal gland |
|
| 34 | general cells |
JCRB0612.1 |
GOTO.P3 |
human |
adrenal grand |
Serum free cell culture of neuroblastoma cell line. |
|
| 35 | general cells |
JCRB0738 |
E1A-3Y1-1 |
rat |
embryo/fetus whole |
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat) |
|
| 36 | general cells |
JCRB1048 |
OVTOKO |
human |
spleen metastatic focus |
Human cell line derived from ovarian tumour. |
|
| 37 | general cells |
JCRB1092 |
NCE SVIA6 |
human |
cervix |
SV40 transformed human keratinocyte cell line. |
|
| 38 | general cells |
JCRB1123 |
HEC-108 |
human |
uterine corpus |
Human tumor cell line from uterine endometrium. |
|
| 39 | general cells |
JCRB1133 |
UE6E7T-2 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 40 | general cells |
JCRB1150 |
KMPC-3 |
human |
right renal pelvis |
Human renal pelvis. |
|
| 41 | general cells |
JCRB1168 |
NCR-G3 |
human |
testis (mixed embrional carcinoma) |
Complex type germ cell tumor of human testis origin. |
|
| 42 | general cells |
JCRB1226 |
GHBP116 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone receptor (GHBP116). |
|
| 43 | general cells |
JCRB1316.5 |
OHP4B2.2.3 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 44 | general cells |
JCRB1320 |
NCC-CoC-K115P |
human |
Colon |
Human colon cancer cell line. |
|
| 45 | general cells |
JCRB1325 |
MKPL-1 |
human |
bone marrow |
A megakaryoblastic leukemia cell line from human acute myeloblastic leukemia. |
|
| 46 | general cells |
JCRB1342.11 |
MOR180.2.4 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 47 | general cells |
JCRB1342.12 |
MOR44.4.1 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 48 | general cells |
JCRB1353 |
TER-119 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse erythrocyte membrane antigen Ly76. |
|
| 49 | general cells |
JCRB1358.08 |
SRBC-F31-19-1 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 50 | general cells |
JCRB1361 |
Vn1919 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
| 51 | general cells |
JCRB1370 |
TAS-5 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin |
|
| 52 | general cells |
JCRB1642 |
KMS-11/BTZ |
human |
pleural effusion |
bortezomib-resistant multiple myeloma cell line. |
|
| 53 | general cells |
JCRB1657 |
HuCCA-1 |
human |
intrahepatic bile duct |
Human cell line derived from cholangiocarcinoma. |
|
| 54 | general cells |
JCRB1813 |
BALM-22 |
human |
bone marrow |
B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
|
| 55 | general cells |
JCRB1843 |
BALM-24 |
human |
peripheral blood |
B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32) |
|
| 56 | general cells |
JCRB1930 |
Me2Tu |
human |
|
Transplanted cell line of malignant pleural mesothelioma TCC-MESO-2 into SCID mice. |
|
| 57 | general cells |
JCRB2223 |
A9(BsrX) |
human chromosome-introduced |
skin |
contains human chromosome X (MTA with Tottori Univ. is required.) |
|
| 58 | general cells |
JCRB4016 |
WILL3 |
human |
bone marrow |
Human diffuse large B-cell lymphoma cell line with two translocations t(14;18)(q32; q21) and t(8;22)(q24;q11). |
|
| 59 | general cells |
JCRB4035 |
Daudi- |
human |
bood |
A clone in which EBV was dropped from Daudi+
|
|
| 60 | general cells |
JCRB4037 |
KMS21R |
human |
bone marrow |
Lenalidomide-resistant human myeloma cell line established by
long-term exposure of KMS21 cells to low concentration lenalidomide for about one year. |
|
| 61 | general cells |
JCRB9023 |
CCRF-CEM |
human |
peripheral blood buffy coat |
Human cell line established from patient with acute lymphoblastic leukemia. |
|
| 62 | general cells |
JCRB9033 |
STK1 |
mouse |
hybridoma |
anti-DNA polymerase alpha, IgG1 |
|
| 63 | general cells |
JCRB9051 |
KG-1 |
human |
bone marrow |
leukemia, acute myelogenous |
|
| 64 | general cells |
JCRB9065 |
G-401 |
human |
kidney |
Rhabdoid tumor of kidney (formerly classified as Wilms' tumor) |
|
| 65 | general cells |
JCRB9095 |
HEPM |
human |
embryo |
embryonic palatal mesenchyme, limited life span |
|
| 66 | general cells |
JCRB9102 |
Detroit 525 |
human |
skin |
Turner's syndrome, skin |
|
| 67 | general cells |
JCRB9125 |
PG-4(S+L-) |
cat |
brain |
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.